Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gumus K et al. – Topical 0.05% cyclosporine A may be a safe and effective long–term treatment of ocular myositis and scleritis. It should be considered as a steroid–sparing agent, particularly in recurrent disease and in those patients who experience adverse effects of systemic medications.

Related Articles

Scleritis and Systemic Disease Association in a Community-Based Referral Practice
American Journal of Ophthalmology, 10/20/09    Relevance Score: 92%

Evaluation of Sub-Tenon Triamcinolone Acetonide Injections in the Treatment of Scleritis
American Journal of Ophthalmology, 10/29/09    Relevance Score: 87%

Today in Clinical Pharmacology...keeping you current

Pharmacological and environmental factors in primary angle-closure glaucoma
British Medical Bulletin, 11/25/09

Vitreous Nonsteroidal Antiinflammatory Drug Concentrations and Prostaglandin E2 Levels in Vitrectomy Patients Treated With Ketorolac 0.4%, Bromfenac 0.09%, and Nepafenac 0.1%
Retina, 11/25/09

Infliximab and anterior optic neuropathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/23/09

Today in Oculoplastics...keeping you current

Optic Disc Diameter Increases During Acute Elevations of Intraocular Pressure
Investigative Ophthalmology and Visual Science, 11/24/09

Increased Generation of Fibrocytes in Thyroid-Associated Ophthalmopathy
Journal of Clinical Endocrinology and Metabolism, 11/24/09

A modified technique of retrograde intubation dacryocystorhinostomy for proximal canalicular obstruction
Clinical Ophthalmology, 11/23/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address